Form 4 for OFIX Orthofix Medical Inc.
Accepted 2023-10-17 00:00:00 ET · period of report 2023-10-15 · accession 0001209191-23-052981 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-10-17 | 2023-10-15 | OFIX | Gillespie Geoffrey C | VP, Ctrl, Interim CFO | A - Grant | $0.00 | +23.3K | 33.1K | +239% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-10-15 | A | A | 23,331 | $0.00 | 33,074 | D | — | — | (F1) Represents time-based vesting restriced stock units that vest in full on the second anniversary of grant date. (F2) Includes 9,743 previously reported restricted stock units. |